Iranian anemia drug draws global attention

Pars Today – News of Iranian scientists’ success in producing the first generation of injectable iron nano-supplements has attracted widespread attention and positive reception from international audiences.

Social media users have highlighted the ingenuity of Iranian scientists and Iran’s historical record of scientific achievements, describing the development and production of the injectable drug “Ferric Carboxymaltose” for rapid, low-side-effect treatment of iron-deficiency anemia as notable and significant.

According to Pars Today, citing Fars News, iron-deficiency anemia is one of the most common nutritional disorders worldwide, affecting over two billion people according to WHO statistics.

A major advantage of the Iranian drug is its ability to deliver high-dose iron—up to 1,000 mg—in a single session without serious side effects, reducing the need for repeated hospital visits and shortening the overall treatment process.

Another advantage of this Iranian product is its high safety profile, which qualifies it for use among patients with kidney disease, cancer patients undergoing chemotherapy, and pregnant women.

Social media users have shared their reactions to the development. For example, a user from Germany wrote:

“I have this condition, but I trust Iran’s scientific expertise.”

Another user, Ali Abbasi, commented: “As I’ve always said, Iranians have the highest IQs in the world. The entire West and the U.S. cannot even imagine what Iranian minds are capable of achieving. This is why they want to sanction Iran—they cannot compete with Iranian intellect.”

One non-Iranian user wrote:

“It’s amazing that Iranian scientists can achieve real innovation without the chains of Big Pharma. God bless the Iranian people. Big pharmaceutical companies block scientific innovation because they prioritize profit, but Iranian scientists can pursue true scientific and innovative work.”

Another X user added:

“Hello to Iran, my spirit is truly with this country.”
(Referring to continuing the second phase of a leukocyte study, indicating ongoing medical research.)

A user named Adbex commented:

“Iran has accomplished something remarkable. Hats off to Iranian doctors and medical staff.”

Bidaki commented:

“Meanwhile, in Israel, a regime that considers itself the ‘most advanced’ in West Asia, children still die from diseases that could be prevented with a simple vaccine!”

Dr. Asama posted under the headline “Good News for the World”:

“This is very important for global health. Iron deficiency affects millions of people worldwide.”